Literature DB >> 34033730

The impacts of parity on spirometric parameters: a systematic review.

Leila Triki1, Helmi Ben Saad2,3,4.   

Abstract

INTRODUCTION: . The relationship between parity and health outcomes has been debated in the scientific literature in terms of "selection-pressure". However, no previous review has raised the impacts of parity on spirometric parameters. This Systematic Review aimed to review the impacts of parity on spirometric parameters. AREAS COVERED: . PubMed and Scopus were searched on October 1st, 2020, using the combination of the following two medical subject headings: "Parity" and "Respiratory Function Tests". Only original articles published in English/French were retained. Ten studies investigated the impacts of parity on spirometric parameters: six included healthy females, three involved unhealthy females [chronic obstructive pulmonary disease, defect in protease inhibitor, and some other conditions] and one included a mixed population of healthy/unhealthy females. The studies reported conflicting results: no impact, positive impact (multiparity is associated with larger forced-expiratory-volume in one second, forced- and slow- vital-capacity, and inspiratory-capacity), or negative impact (multiparous females has lower bronchial flows, higher static volumes, an accelerated lung-aging, a tendency to an obstructive-ventilatory-defect and/or to lung-hyperinflation, and increased protease inhibitor levels). EXPERT OPINION: The ten studies presented some limitations that made data interpretation relatively difficult. Future research to identify the "real" impact of parity on spirometric parameters are therefore encouraged.

Entities:  

Keywords:  Childbearing; Methodology; Parity; Plethysmography; Spirometry

Year:  2021        PMID: 34033730     DOI: 10.1080/17476348.2021.1935246

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  1 in total

1.  Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease.

Authors:  Subash S Heraganahally; Timothy Howarth; Lisa Sorger; Helmi Ben Saad
Journal:  PLoS One       Date:  2022-02-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.